AVEO Oncology said that data from a planned interim analysis of the phase II BATON (Biomarker Assessment of Tivozanib in ONcology) study in patients with colorectal cancer indicate that the study is unlikely to meet the primary endpoint in the intent-to-treat patient population.
Ludwig Cancer Research donated a total of $540 million to six of its centers, located at institutions across the country.
Orlando Health Center's Mark RohDownload and listen to this conversation here.Orlando Health is choosing a partnership over an affiliation, said Mark Roh, president of the Florida cancer center that's ending its relationship with MD Anderson Cancer Center.
On Jan. 30, somebody will have to climb to the top of Orlando Health's 10-story Charles Lewis Pavilion to cover up—or start removing—the backlit letters that, with a halo effect created by LED lights, broadcast the health system's affiliation with MD Anderson Cancer Center.
Bipartisan Deal Eases Some Budget Cuts By Extending Sequestration Through 2023By Matthew Bin Han Ong
